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Objectives: The knee can be injected at different anatomic sites with or without image-guidance. We
undertook a systematic review to determine the accuracy of intra-articular knee injection (IAKI) and
whether this varied by site, use of image-guidance, and experience of injectors, and whether accuracy of
injection, site, or use of image-guidance inﬂuenced outcomes following IAKIs.
Methods: Medline, Embase, AMED, CINAHL, Web of Knowledge, Cochrane Central Registers for Con-
trolled Trials up to Dec 2012 were searched for studies that evaluated either accuracy of IAKIs or
outcomes related to accuracy, knee injection sites, or use of image-guidance. Within-study and between-
study analyses were performed.
Results: Data from 23 publications were included. Within-study analyses suggested IAKIs at the super-
omedial patellar, medial midpatellar (MMP), superolateral patellar (SLP) and lateral suprapatellar bursae
sites were more accurate when using image-guidance than when blinded (ranges of pooled risk difference
0.09–0.19). Pooling data across studies suggested blinded IAKIs at the SLP site were most accurate (87%)
while MMP (64%) and anterolateral joint line (ALJL) sites were (70%) least accurate. Overall about one in ﬁve
blinded IAKIs were inaccurate. There was some evidence that experience of the injector was linked with
improved accuracy for blinded though not image-guided injections. Based on a small number of studies,
short but not longer-term outcomes for ultrasound-guided were found to be superior to blinded IAKIs.
Conclusions: Image-guided IAKIs are modestly more accurate than blinded IAKIs especially at the MMP and
ALJL sites. Blinded injections at SLP site had good accuracy especially if performed by experienced injectors.
Further studies are required to address the question whether accurate localization is linked with an
improved response.
& 2013 The Authors. Published by Elsevier HS Journals, Inc. Open access under CC BY-NC-ND license.Introduction
The knee is one of the commonest target joints for intra-
articular injection therapy [1–4]. There are a number of possible
anatomic injection sites [5–7]. Clinicians' choice of technique is
often inﬂuenced by their experience and training.
It seems likely that increased accuracy of localization of the
injection within the joint should improve treatment response.
However, unlike shoulder injections where there is established
evidence for using image-guided injections [1,8–12], the evidencer HS Journals, Inc.
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Open access under CCbase for needle-guidance during intra-articular knee injections
(IAKI) is weaker. It remains uncertain whether approaches for
localization such as using air arthrogram [13,14], ﬂuoroscopy [15],
ultrasound [16,17], and magnetic resonance imaging (MRI) [18]
actually improve IAKI accuracy. Also it remains unclear whether
improved accuracy is associated with better clinical response.
We undertook a systematic review with the aim of determining—
(i) the accuracy of IAKI and whether this varied by site, imaging, and
experience of injectors and, (ii) whether accuracy, site of injection, or
the use of image-guidance were linked with therapeutic response.
We also undertook a meta-analysis of the accuracy of “blinded”
(without image-guidance) vs guided IAKI (with image-guidance).Methods
Search strategies
Publications that looked at accuracy of IAKIs or clinical outcome
associated with intra-articular needle placement, delivered BY-NC-ND license.
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ﬁed from searching six databases up to Dec 2012: Medline (1948
onwards), Embase (1974 onwards), AMED (1985 onwards), Cumu-
lative Index to Nursing and Allied Health Literature (CINAHL) Plus
(1937 onwards), Web of Science (1950 onwards), and the Cochrane
Central Registers for Controlled Trials. The databases were
searched individually for all possible terms and combination of
terms to accommodate differences in their search engines. All
medical subject-heading searches (MeSH) were explored when
possible. The key terms used in combination (“AND”) were knee,
intra-articular, injection, aspiration, trials, and accuracy.
Study selection criteria
In this review, injection “sites” refer to speciﬁc areas in the knee
for needle entry and injection “approaches” refer to techniques of
delivering the injections or aspirations including angling of the
needle or position of the knee, ﬂexed or extended. Guided IAKIs
included any needle-guidance techniques to assist getting into the
joint such as injections or aspirations aided by ultrasound, ﬂuoro-
scopy, or air-arthrography. For assessing accuracy of IAKI, we
included studies that used participants with knee osteoarthritis
(OA), inﬂammatory arthritis, mixed samples of OA and inﬂamma-
tory arthritis, those without knee pathologies, and cadavers. For
formal comparison of blinded and guided IAKI, we included
studies that used at least two treatments arms; one delivering
blinded injection at a particular site and another using guided
injection at the same site, allowing within-study comparison. We
found that most studies provided information about one treatment
arm only. To maximize utilization of the available data, we there-
fore included a between-study comparison of the various injection
sites pooling the accuracy of blinded and guided IAKIs separately.
There were too few data to look at outcome in relation to accuracy
and knee injection sites; however, we were able to pool data in
relation to the inﬂuence of image-guidance on outcome. Outcome
measures relating to treatment response were not speciﬁed a
priori.
Knee joint injection accuracy
Accurate IAKI occurs when the needle is placed within the
intra-capsular joint space and inaccurate injection when the
needle is placed extra-articularly or gets embedded into other
intra-capsular tissues such as plica. To determine the accuracy of
IAKI, a number of approaches are available such as injection of
contrast or air with radiography [13,14], sonography [19] or
ﬂuoroscopy [20], magnetic resonance imaging (MRI) [18], surgical
conﬁrmation of intra- or extra-articular placement of drugs
[21,22], and for aspiration successful removal of synovial ﬂuid.
There is no gold standard for assessing accuracy of IAKI. It is
recognized that all these techniques are subject to a degree of
observer error in evaluation of the images while surgical con-
ﬁrmation is too invasive for routine use. In this review, we
included all studies that made an independent attempt to corrob-
orate intra-articular placement including successful aspiration of
synovial ﬂuid. For this review, the results on accuracy of the sites
of injection were tabulated by injection site and also whether
image-guidance was used or not. We did not look separately at
accuracy by method of image-guidance.
Quality assessment
For randomized controlled trials (RCTs), study quality was
graded using the Jadad score [23]. Concealment to treatment
allocation was scored as adequate, inadequate, or unclear if there
was insufﬁcient information to make the judgment [24]. Forobservational studies, “Strengthening the Reporting of Observa-
tional Studies in Epidemiology” (STROBE) checklist of 22 items was
used to assess quality [25] with close reference to further elabo-
ration and explanation of the criteria given in another publication
of the STROBE statement [26]. For non-RCT, quality was assessed
using the “Transparent Reporting of Evaluations with Non-
randomized Designs” (TREND) checklist [27]. The data were
extracted independently by two reviewers (N.M. and M.J.P.). Two
assessors (N.M. and M.J.C.) independently assessed and scored the
publications for quality and reached consensus in cases of
disagreement.
Data extraction and analyses
A ﬁxed-effects meta-analysis was used to pool those studies
that evaluated a speciﬁc injection site under both blinded and
guided conditions within the same trial (within-study analyses).
Heterogeneity in trial outcomes was assessed using the I2 statistic.
Results of other studies evaluating accuracy of speciﬁc injection
sites were also pooled (between-study analyses). Accuracy was
assessed as the percentage of those injected in which the injection
was correctly localized. For within-study comparisons, difference
in accuracy (guided vs blinded) was assessed using absolute risk
difference (ARD) with associated 95% conﬁdence intervals (CI),
where the risk ratio is the “risk” of an accurate injection in the
guided group to the “risk” of an accurate injection in the blinded
group. For between-study comparisons, difference in accuracy
between groups was assessed also using the chi-square statistic
and relative risk (RR). We used a ﬁxed-effects meta-analysis to
pool data looking at outcomes in relation to use of image-guidance
(ultrasound). Results were considered signiﬁcant if p-values were
less than 0.05 (two sided) or if the 95% CI of the RR and ARD did
not include one and zero, respectively.Results
Search outcome
From all databases, 710 publication records were retrieved and
302 duplicates eliminated (Fig. 1). Text-words from 408 records
were screened, and of these, 296 records failed to meet study
selection criteria. Of the 112 abstracts read, 56 were not relevant
and were excluded. A further 56 full-text articles were read for
eligibility. Of these 33 were rejected for not evaluating accuracy of
IAKI sites, blinded or guided IAKIs, or clinical outcome associated
with intra-articular needle placement. Twenty-three publications
ﬁnally met the inclusion criteria (Fig. 1); some of these addressed
accuracy only, others both accuracy and treatment outcome
(Table 1).
Twelve of 23 studies were RCTs, three non-RCTs, and eight
observational studies. Twenty-two publications addressed accu-
racy of IAKIs and/or aspiration, seven assessed accuracy of IAKIs at
different sites [14,15,21,22,28–30], four at one injection site
[20,31–33], and 13 compared blinded and guided IAKIs
[2,13,19,20,28,30,34–40]. Of the six studies that reviewed clinical
outcomes, one was pertaining to accuracy of IAKI [29], two
compared between different knee injection sites [28,33], and three
compared outcomes between guided and blinded IAKIs [40,41]
(Table 1). In two papers, the injection site was not speciﬁed during
blinded IAKIs [2,4]. There were also two studies that investigated
knee injections performed at the same site but using different
approaches depending on the angling of the needle or the position
of the knee, ﬂexed or extended [28,29]; though in one of these
studies, the accuracy relating to each approach was not formally
assessed [28]. In three papers [14,20,30] the authors were
No. of studies for qualitative synthesis n=23:
- For IAKI approaches and accuracy = 22
- For IAKI clinical outcome = 6
Duplicates (n=302)
Records identified from all sources (n=710)
MEDLINE 199
AMED 122
Embase 110
Cochrane Register 117
Web of Knowledge 155
CINAHL 5
Others 2
No. of records screened 408
No. of abstract read 112
No. of full text read 56
Not relevant to study questions (n=56)
No. of full text articles excluded (n=33), reasons:-
•     Reviews of Treatment 5
•     Injection not in knee joint 5
•     Did not consider accuracy and comparison 
of outcomes of knee injections                       23
Fail to meet study selection criteria (n=296)
Fig. 1. Summary of search results.
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The required information was obtained for one of the studies [20];
in the others [14,30], site of knee injections was designated as
unknown.
Data quality
For the 12 RCTs, only ﬁve had Jadad scores of three and above
[2,29,35–37] and were deemed as high-quality trials [42] and ﬁve
had adequate allocation concealment [2,29,35,36,39] (see Supple-
mentary Tables S1–S3). Others were single-blinded trials where
either patients or injectors were not blinded to the intervention
groups. For the observational studies, seven of eight studies
fulﬁlled 10–18 of the 22 STROBE criteria [4,13,19,21,31,32,38],
while all three non-randomized trials had TREND scores of 10–
15 of 22 [14,15,34] (see Supplementary Tables S1–S3).Knee joint injection sites and approaches
Publications included in this review sometimes used different
terms to describe the sites of injections, but by using the enclosed
descriptions of how the injections were performed including
diagrams or pictures, we were able to identify eight different
injection sites. These included medial injection techniques such as
over the anteromedial joint line (AMJL), medial midpatellar
(MMP), and superomedial patellar (SMP) and lateral injection
techniques over the anterolateral joint line (ALJL), lateralmidpatellar (LMP), superolateral patellar (SLP), lateral suprapatel-
lar bursa (LSB), and also infrapatellar (IFP) (Fig. 2). In ﬁve
publications sites were classiﬁed as “unknown.” Infrapatellar site
was used least and evaluated in one publication only.
Thirteen approaches at eight sites were described during
blinded IAKIs. For anteromedial joint line injection, the needle
was inserted within the portal formed by inferomedial patellar
border, patellar tendon, and medial tibial plateau, directing the
needle toward intercondylar notch with the knee extended [21] or
ﬂexed 301 [29] or 901 [15,29]. With the medial midpatellar, the
injection was made between patella and patellar groove of femur
at mid medial patellar junction with the knee extended
[21,33,37,39]. The superomedial patellar injection was performed
with the needle inserted in a 451 cephalomedial to caudolateral
direction between the femoral condyle and the lateral border of
patella at the superior one-third margin of the patella with the
knee extended [38].
In contrast, the anterolateral joint line injection could be
performed using four approaches with the needle inserted within
the portal formed by inferolateral patellar border, patellar tendon,
and lateral tibial plateau directing the needle towards intercondy-
lar notch with the knee ﬂexed [15,21] or directing the needle
toward medial femoral condyle with the knee extended [28] or
ﬂexed between 301 and 401 [20] or ﬂexed to 901 [28]. For lateral
midpatellar approach, the injection was made between patella and
patellar groove of femur at mid lateral patellar junction with the
knee in an extended position [15,21,39]. In the superolateral
patellar injection, the needle was inserted 1 cm above and 1 cm
Table 1
Published papers
Authors Phenotype Intervention Method for assessing
accuracy
Assessment
Balint et al.
[34]
Knee OA and RA Aspiration of synovial
ﬂuid
Successful aspiration Accuracy: blinded (unknown site) vs ultrasound-guided (via LSB)
Bliddal [13] Knee OA Steroid/local
anesthetic/air
Air on XR Accuracy and outcome: blinded vs air-arthrography guided via SLP
Bum Park et al.
[35]
Knee OA Hyaluronic acid XR þ contrast Accuracy: blinded vs ultrasound-guided via LSB
Chavez-Chiang
et al. [28]
Knee OA Steroid/local
anesthetic
Ultrasound Treatment outcome: blinded injection via LMP and LJL (knee extended)
Accuracy: ultrasound-guided via LJL (knee ﬂexed)
Cunnington
et al. [2]
Inﬂammatory
arthritis
Aspiration of synovial
ﬂuid
XR þ contrast Accuracy and outcome: blinded vs ultrasound-guided
Curtiss et al.
[36]
Cadaveric knees Methylene blue Dissection Accuracy: blinded (SLP) vs ultrasound-guided (LSB)
Esenyel et al.
[21]
Cadaveric knees Methylene blue Dissection Accuracy: blinded injection via MJL, MMP, LJL, and LMP
Glattes et al.
[14]
Knees needing
injection
Local anesthetic XR þ contrast
“Squishing sound” test
Accuracy: blinded injection via SLP
Im et al. [37] Knee OA Hyaluronic acid XR þ contrast Accuracy: blinded vs ultrasound-guided via MMP
Jackson et al.
[15]
Knee OA Hyaluronic acid Fluoroscopy Accuracy: blinded injection via AM, AL, and LMP
Jones et al. [4] Knee OA and RA Steroid XR þ contrast Accuracy and outcome: blinded injection
Lopes et al. [31] Inﬂammatory
arthritis
Steroid XR þ contrast Accuracy and outcome: blinded injection
Luc et al. [32] Knee OA Local anesthetic XR þ contrast “Backﬂow
of ﬂuid” test
Accuracy: blinded injection via SLP
Myung et al.
[38]
Knee OA Hyaluronic acid Fluoroscopy Accuracy: blinded vs ﬂuoroscopy-guided via SMP
Park et al. [39] Knee OA Steroid/local XR þ contrast Accuracy: ultrasound-guided via MMP, LMP, and SLP
Qvistgaard
et al. [19]
Knee OA Hyaluronic acid/local
anesthetic/air
Air on ultrasound image Accuracy: ultrasound-guided via SLP
Shah and
Wright [33]a
Knee OA Steroid Dissection Outcome: blinded M vs IFP injection
Shah and
Wright [33]b
Cadaveric knees Methylene blue Accuracy: blinded injection via IFP
Sibbitt et al.
[40]
Knee OA and RA Aspiration of synovial
ﬂuid
Successful aspiration Accuracy and outcome: blinded vs ultrasound-guided aspiration via LSB
Sibbitt Jr et al.
[41]
Knee OA Steroid/local
anesthetic
– Outcome: blinded vs ultrasound-guided via AMJL
Toda and
Tsukimura
[29]
Knee OA Hyaluronic acid XR þ contrast Accuracy and outcome: blinded injection via MJL (ﬂexed 30◦), MJL (ﬂexed 90◦),
and LMP
Waddell et al.
[20]
Non-arthritic
kneesc
Methylene blue XR þ contrast Accuracy: ﬂuoroscopy-guided via ALJL
Wiler et al. [30] Effused knees Aspiration of synovial
ﬂuid
Successful aspiration Accuracy and outcome: blinded vs ultrasound-guided
Wind and
Smolinski
[22]
Knees undergoing
arthroscopy
Hyaluronic acid/
methylene blue
Arthroscopy Accuracy: blinded injection via SMP, SLP, and LJL
Abbreviations: OA, osteoarthritis; RA, rheumatoid arthritis; M, medial; L, lateral; MP, medial patellar; IFP, infrapatellar; AM, anteromedial; AL, anterolateral; MMP, medial
midpatellar; SMP, superomedial patellar; MJL, medial joint line; LMP, lateral midpatellar; SLP, superolateral patellar; LJL, lateral joint line; LSB, lateral suprapatellar bursa.
a Trial comparing outcomes of knee injections delivered at two sites in 36 patients.
b Trial to determine infrapatellar injection accuracy using four OA cadaveric knees.
c Six of the 11 participants had a history of knee complaints. Shaded row: within-study analyses.
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lateral to caudomedial direction with the knee extended
[14,22,29,32,39]. During lateral knee injection into the supra-
patellar bursa, the needle was inserted from superolateral aspect
of patella, one-ﬁngerbreadth above and one-ﬁngerbreadth lateral
to the patella with the knee extended [35,40]. The infrapatellar
injection was performed over the lateral condyle of tibia with the
needle directed upwards and medially while the knee was in a
ﬂexed position [33].
For studies that performed guided IAKIs, two medial sites,
MMP [37,39] and SMP [38] and four lateral sites, ALJL [20,28], LMP
[39], SLP [13,39], and LSB [2,19,34–36,40] were used. The lateral
sites were more commonly used during guided IAKIs while
blinded injections were more frequently delivered through
medial sites.Within-study analyses
Guided vs blinded IAKIs
Five studies were included in the within-study analyses and
these involved four injection sites (Fig. 3).
Statistical heterogeneity of the ﬁve pooled studies was small (I²
¼ 28%). For the two pooled studies on LSB using ultrasound-
guided IAKIs, there was no statistical heterogeneity (I² ¼ 0%).
Guided IAKIs at MMP, SMP, LSB, and SLP sites were found to be
signiﬁcantly more accurate (ranges pooled ARD 0.09–0.19; p o
0.05) than their respective blinded injections (Fig. 3). The accuracy
of medial sites (ranges of pooled ARD 0.18–0.19) was improved to a
greater extent than the lateral sites (pooled ARD ranges 0.09–0.14)
by guided injections. Of all the four sites, compared to a blinded
Fig. 2. Injection sites in knee.
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image-guidance using air-arthrography.Between-study analyses
Accuracy: Inﬂuence of injection site, image-guidance, and experience
of clinician
Blinded
Of the three medial sites at which blinded injections were
performed, the SMP site was linked with greatest accuracy of
injection (82%), followed by AMJL (74%) and MMP (64%) (Table 2).
One publication reported that injections performed at AMJL with
knees ﬂexed to 301 was more accurate (p ¼ 0.035) than knees
ﬂexed to 901 [29].
Of the four lateral sites at which blinded injections were
performed, the SLP site was linked with greatest accuracy of
injection (87%), followed by LMP (84%), LSB (83%), and ALJL
(70%) (Table 2).
Guided
Of the two medial sites investigated during guided IAKIs, the
SMP site was linked with greatest accuracy (100%) while MMP
improved to 86% with image-guidance (Table 2). Based on a pooled
study comparison, IAKIs at the MMP (ARD 0.22; 95% CI, 0.10–0.33;
p ¼ 0.0005) and SMP sites (ARD 0.18; 95% CI, 0.14–0.22; p
o 0.0001) were signiﬁcantly more accurate using image-
guidance than when given blinded (Table 3). No studies evaluated
the AMJL site.
Pooling data across studies (Table 2), all four lateral sites (ALJL,
LMP, SLP, and LSB) had excellent accuracy, 95–100%, when per-
formed guided, though the best lateral site was still the SLP. Based
on a pooled study comparison, there was a signiﬁcant improve-
ment in the accuracy of injections at LSB and SLP sites (pooled ARD
0.13–0.15; p r 0.0001) while LMP site also improved (ARD 0.12;
95% CI 0.001–0.20; p ¼ 0.05) with image-guidance (Table 3). IAKIs
at ALJL were highly more accurate when guided (ARD 0.28; 95% CI,
0.20–0.35; p o 0.0001) (Table 3).
Experience
Blinded. Of four publications, only one study was designed
formally to investigate the impact of injectors' experience on theaccuracy of IAKI. The study found that the injector's experience
inﬂuenced the accuracy rate of blinded injections at the SLP site;
accuracy rate of 55% (95% CI 34–74) for the less experienced
injector compared to 100% (95% CI 81–100) for the more
experienced injector [36]. Luc et al. [32], however, in their trial
of 33 knee injections reported a similar accuracy for blinded
injections at the SLP site for a clinical fellow (96%) and
experienced rheumatologist (100%). Two other publications that
included “unknown” sites of blinded knee injections found similar
accuracy irrespective of the level of experience, seniority, and
training [2,4].
Guided. Similar accuracy was found for less experienced junior
clinicians and injectors with more experience during guided IAKIs
[2,32]. Cunnington et al. [2] reported 91% accuracy when a
research fellow performed the injections using sonographic-
guidance while Luc et al. [32] reported 100% accuracy when a
medical fellow used “backﬂow of injected ﬂuid” during IAKIs to
conﬁrm intra-articular placement of needles.Outcome
Because of small numbers and differences in study design, it
was not possible to pool data from those studies that looked at
outcome associated with either accuracy or site of injection. There
were three studies that reported outcomes related to use of image-
guidance (using ultrasound); one was conducted on subjects with
knee OA without effusion [41], another on OA and RA knees with
effusion [40], and a third in knees with effusion [30]. Figure 4
shows the forest plots for two of these studies that suggested
better pain reductions at 2 weeks with guided IAKIs [40,41]; no
outcome data on pain was available in the third [30]. There was no
difference in longer-term pain-relief, though duration of response
was a month longer with ultrasound-guidance [41]. Using volume
of synovial ﬂuid aspirated as the outcome, image-guidance was
associated with greater volume aspirated (see Fig. 4).
Discussion
In this systematic review, blinded IAKIs overall were reasonably
accurate, in particular the lateral injection sites. The use of needle-
guidance improved the accuracy of IAKIs signiﬁcantly. There was,
Study or Subgroup
Superolateral Patellar
Bliddal 1999
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 2.18 (P = 0.03)
Lateral Suprapatellar Bursa
Bum Park 2012
Sibbitt 2012
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.32, df = 1 (P = 0.57); I² = 0%
Test for overall effect: Z = 2.92 (P = 0.003)
Medial Mid Patellar
Im 2009
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 2.60 (P = 0.009)
Superomedial Patellar
Myung 2007
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 9.25 (P < 0.00001)
Total (95% CI)
Total events
Heterogeneity: Chi² = 5.59, df = 4 (P = 0.23); I² = 28%
Test for overall effect: Z = 10.08 (P < 0.00001)
Test for subgroup differences: Chi² = 5.11, df = 3 (P = 0.16), I² = 41.3%
Events
56
56
48
42
90
43
43
368
368
557
Total
56
56
50
42
92
45
45
368
368
561
Events
51
51
41
18
59
34
34
298
298
442
Total
56
56
49
22
71
44
44
368
368
539
Weight
10.2%
10.2%
9.1%
5.3%
14.3%
8.1%
8.1%
67.3%
67.3%
100.0%
M-H, Fixed, 95% CI
0.09 [0.01, 0.17]
0.09 [0.01, 0.17]
0.12 [0.01, 0.24]
0.18 [0.02, 0.35]
0.14 [0.05, 0.24]
0.18 [0.05, 0.32]
0.18 [0.05, 0.32]
0.19 [0.15, 0.23]
0.19 [0.15, 0.23]
0.17 [0.14, 0.21]
Guided Blinded Risk Difference Risk Difference
M-H, Fixed, 95% CI
-0.2 -0.1 0 0.1 0.2
Favors blinded injection Favors guided injection
Fig. 3. Forest plot—Injection accuracy of guided vs blinded knee injections.
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of knee injections resulted in an improved therapeutic outcome.
The use of ultrasound-guided IAKIs though may lead to better
short-term beneﬁt.
We found good accuracy with most lateral approaches even
when performed blinded, suggesting clinicians have a choice when
selecting injection sites over the lateral aspect of the knee.
However, due to a relatively low accuracy of ALJL injection when
undertaken blinded (70%), we suggest it might be better under-
taken with image-guidance. We also found the MMP was the least
accurate site for both blinded and guided injections. A possible
explanation for this is that with the approach the needle may
engage with the medial knee plica or fat pad [3,43]. Medial
injections with a partially ﬂexed knee are deemed anecdotally
least successful, more painful, and most likely to be loculated
[43,44]. However, although there were few studies, our review did
not ﬁnd any signiﬁcant difference in accuracy when injections
were performed with the knee in extension or ﬂexion.
Accuracy of injection for ultrasound-guided injections was not
improved except with injection of the anterior lateral joint line site
The experience of injectors may inﬂuence the accuracy of
blinded injections [4,36] though further studies are needed. In
contrast, image-guided knee injections can be delivered accurately
independent of the injector's experience (including junior clini-
cians with a short training period) [2,32]. This perhaps indicates
that delivering an injection blinded using anatomical palpation
may require experiential learning.
From the pooled data across studies, all four lateral sites (ALJL,
LMP, SLP, and LSB) had excellent accuracy, 95–100%, when per-
formed guided though the best lateral site was SLP. Both within-
study and between-study analyses found that guided injections,
irrespective of sites of injection, to be more accurate than blinded
injections. Overall it can be estimated that approximately one inﬁve blinded injections are inaccurate. Other reviews have found
similar ﬁndings with respect to accuracy of blinded vs guided
injections [45] and blinded injections at the LMP and AMJL sites
[46]. Daley et al. [1] pooled seven papers evaluating three knee
injection sites and a total of 429 injections but excluded trials
investigating accuracy of IAKIs performed on cadaveric knees. Our
review included more papers that have been published since then,
pooling results from 22 studies, evaluating accuracy of eight
injection sites, and totaling 2735 knee injections. Herman [46]
though, who included cadaveric samples, found a lower accuracy
for the MMP [56% (95% CI 45–66)] and ALJL sites [67% (95% CI
43–91)] but higher accuracy for the SLP [91% (95% CI 84–99)] and
SMP sites [93% (95% CI 81–98)]. The reason for the differences in
values could be due to the smaller number of publications available
at the time of their review and unlike Hermans [46], our review
grouped injections performed over the lateral joint line as ALJL
irrespective of the degree of ﬂexion or extension of the knees.
In this review, guided injections were undertaken primarily using
ultrasound. Only three of the 15 publications that evaluated accuracy
of IAKIs used other guided techniques such as air-arthrography [13]
and ﬂuoroscopy [20,38]. When analysis of accuracy of IAKIs was
assessed for ultrasound-guided injections only, accuracy of all sites
remained the same with the exception of the ALJL site where
accuracy reduced slightly to 97%. The SMP site has not been
evaluated for accuracy, perhaps reﬂecting the difﬁculty of the ultra-
sound technique when performed over the medial aspect of the knee.
In two studies, ultrasound was used to both guide and assess
accuracy. In one, conﬁrmation of accuracy was determined by the
appearance of an injected volume of air (air bubble) within the
knee joint on the ultrasound image [19]. A limitation of this
method though is that the evidence of placement lasts only a
few seconds as the air bubbles soon dissolve and disappear. The
other trial did not describe how accuracy was determined [28].
Table 2
Accuracy of blinded and guided knee injections
Blinded knee approach: accuracy, no. out of total (%) Guided knee approach: accuracy, no. out of total (%)
Lead author Medial injections Lateral injections Unknown Medial injections Lateral injections Unknown
AMJL MMP SMP ALJL LMP SLP LSB IFP MMP SMP ALJL LMP SLP LSB
Balint et al. [34] 4/10 (40) 18/19 (95)
Bliddal [13] 51/56 (91) 56/56
(100)
Bum Park et al. [35] 41/49
(84)
48/50 (96)
Chavez-Chiang et al.
[28]
74/76 (97)
Cunnington et al. [2] 27/33 (82) 32/35 (91)
Curtiss et al. [36] 31/40 (78) 40/40 (100)
Esenyel et al. [21] 57/78 (73) 44/78 (56) 66/78 (85) 58/78 (74)
Glattes et al. [14] 20/20 (100)
Im et al. [37] 34/44 (77) 43/45
(96)
Jackson et al. [15] 60/80 (75) 57/80 (71) 74/80 (93)
Jones et al. [4] 39/59 (66)
Lopes et al. [31] 37/37 (100)
Luc et al. [32] 32/33 (97)
Myung et al. [38] 298/368
(81)
368/368
(100)
Park et al. [39] 30/40
(75)
41/43
(95)
43/43
(100)
Qvistgaard et al. [19] 184/184
(100)
Shah and Wright [33] 4/4
(100)
Sibbitt et al. [40] 18/22
(82)
42/42 (100)
Toda and Tsukimura
[29]
74/100 (74) 35/50 (70)
Waddell et al. [20] 20/20
(100)
Wiler et al. [30] 25/27 (93) 37/39
(95)
Wind and Smolinski
[22]
40/43 (93) 19/44 (43) 39/44 (89)
SUBTOTAL 191/258
(74)
78/122
(64)
338/411
(82)
142/202
(70)
132/158
(84)
225/260
(87)
59/71
(83)
4/4
(100)
115/149
(77)
73/85
(86)
368/368
(100)
94/96 (98) 41/43
(95)
99/99
(100)
364/370
(98)
37/39
(95)
TOTAL 607/791 (77) 562/695 (81) 115/149
(77)
441/453 (97) 598/608 (98) 37/39
(95)
GRAND TOTAL 1284/1635 (79) 1076/1100 (98)
Abbreviations: AMJL, anteromedial joint line; MMP, medial midpatellar; SMP, superomedial patellar; ALJL, anterolateral joint line; LMP, lateral midpatellar; SLP, superolateral patellar; LSB, lateral suprapatellar bursa; IFP,
infrapatellar.
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Table 3
Accuracy of knee injection: inﬂuence of site and image-guidance—Relative and absolute risk difference*
Knee injection site Relative risk
(95% conﬁdence Interval)
Absolute risk difference
(95% conﬁdence interval)
Chi squared2, p-value
Medial midpatellar (guided vs blind) 1.34 (1.15–1.57) 0.22 (0.10–0.33) 12.17, p ¼ 0.0005
Superomedial patellar (guided vs blind) 1.22 (1.16–1.27) 0.18 (0.14–0.22) 72.03, p o 0.0001
Anterolateral joint line (guided vs blind) 1.39 (1.27–1.53) 0.28 (0.20–0.35) 30.03, p o 0.0001
Lateral midpatellar (guided vs blind) 1.14 (1.04–1.26) 0.12 (0.001–0.20) 3.91, p ¼ 0.05
Superolateral patellar (guided vs blind) 1.15 (1.10–1.21) 0.13 (0.10–0.18) 14.73, p ¼ 0.0001
Lateral suprapatellar bursa (guided vs blind) 1.18 (1.07–1.32) 0.15 (0.08–0.26) 35.44, p o 0.0001
Medial knee injections as a group (guided vs blind) 1.27 (1.21–1.32) 0.21 (0.17–0.24) 92.13, p o 0.0001
Lateral knee injections as a group (guided vs blind) 1.22 (1.17–1.26) 0.17 (0.14–0.20) 101.48, p o 0.0001
Guided vs Blinded injections as a group 1.24 (1.21–1.27) 0.19 (0.17–0.21) 124.54, p o 0.0001
Blinded knee injections: lateral vs medial as a group 1.05 (1.00–1.12) 0.04 (0.00–0.08) 3.75, p ¼ 0.05
Guided knee injections: lateral vs medial as a group 1.01 (0.99–1.03) 0.01 (0.01 to 0.03) 1.29, p ¼ 0.3
n Relative risk is the proportionate difference in accuracy of injections (between groups as deﬁned in each row) while absolute risk difference is the absolute difference in
accuracy.
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however, affect the results.
Few studies identiﬁed in this review attempted to correlate
accuracy of knee injection with treatment outcome. Indeed there
was only one trial on knee OA; this trial reported better outcome
for accurate injections when compared to inaccurate IAKIs [29].
Two other studies [2,4] evaluated outcomes of accurate IAKIs
together with outcomes from other joints injections (including
shoulder, elbow, wrist, ankle, ﬁnger, and acromioclavicular joints)
making it difﬁcult to assess outcome speciﬁcally at the knee joint.
Accuracy of injection varies at different joint sites and for studies
that pooled data across many joints, it might have been more
informative if treatment outcome was reported by joint [2,4,47].
For trials that used a mixed sample of OA and RA such as that by
Sibbitt et al. [40], it would have been helpful also if the ther-
apeutic response in the OA group was presented separately from
the RA group as it is possible that disease type may have
inﬂuenced outcome. In a separate trial, compared to those whose
injections were targeted within the joint, there was no difference
in outcome in those where the injection was delivered extra-
articularly [48].
There were also only two studies that compared outcome
between different knee injection sites but found no difference
between those sites [28,33], that is, between LMP and ALJL [28]
and IFP and medial knee injections [33], though in the latter studyFig. 4. Forest plot—Outcome of guidthe IFP site was associated with less frequent joint aspiration and
worse patients' perceived improvement [33].
For outcome relating to IAKIs, the best studied issue has been a
comparison of outcomes of ultrasound-guided vs blinded injec-
tions, though accuracy of these injections was not assessed. From
the few studies, ultrasound-guided injections resulted in better
aspiration [40] and short-term therapeutic beneﬁt than blinded
IAKIs [40,41].
There are a number of limitations to be considered when
interpreting the results of this review. First, there were relatively
few studies that permitted within-study analyses of the accuracy of
blinded vs guided injections. There was, however, little evidence of
statistical heterogeneity of the pooled studies suggesting a low risk
of bias. Second, we included studies investigating the accuracy of
IAKIs performed on cadavers [21,36] where it may be argued that
altered tissue properties could affect the outcome (accuracy of
injection). However, the use of knee dissections to verify accurate
placement of injected materials provide direct evidence in contrast
to relying on interpretation of the spread of contrast material on
radiographs during imaging to deduce intra-articular placement. We
analyzed our data by including and excluding cadaveric studies and
found accuracy for SLP and LSB to be comparable while for ALJL and
LMP to be slightly higher if the cadaveric studies were excluded.
Third, it is possible that accuracy of injection sites could also be
inﬂuenced by the method of assessment of injection accuracyed vs blinded knee injections.
N. Maricar et al. / Seminars in Arthritis and Rheumatism 43 (2013) 195–203 203(including observer variability), though generally there was a trend
for greater accuracy irrespective of the assessment method.Conclusion
Blinded IAKIs can be performed with reasonably good accuracy,
though accuracy does vary by injection site and is improved with
needle-guidance. Injectors' experience may inﬂuence the accuracy
of blinded injections. Further studies are required to address the
question whether accurate localization is linked with an improved
clinical outcome.Acknowledgments
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